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NanoImpactNet (NIN) is the European network on the health and environmental impact of 
manufactured nanomaterials (MNMs). Functioning primarily as a coordination action and a 
multidisciplinary platform for exchanging research ideas, NIN shares outputs with 
stakeholders from academia, industry, professional associations, legislators, regulators, and 
civil society across Europe and beyond. NIN identifies stakeholders' interests and needs to 
improve this communication. 
 
NIN has organised a series of workshops to discuss who needs or wants to know what, and 
how this can be facilitated, with the ultimate goal of a healthy future in a world with MNMs. 
Scientific cooperation and dialogue between researchers and other stakeholders were the 
staring points for these three meetings on: 
 
1. Defining knowledge gaps in current research on MNM characterisation for use in life 
cycle assessments, as well as identifying MNM behaviour in the environment. 
2. ‘How to make industrial data available’ - strategies for sharing potentially sensitive 
proprietary (or negative) data and for allowing the comparison of protocols. 
3. ‘How to inform the public about nano-enhanced food contact materials’ – a sensitive and 
potentially contentious debate will ensue if legislation fails to encourage communication. 
 
All stakeholders agree that much more scientific data must be generated and shared, notably 
on: potential toxic and safety hazards of MNMs throughout their lifecycles; fate and 
persistence of MNMs in humans, animals and the environment and thus risks associated 
with MNM exposure, for which researchers and workers are in the front line. Also highlighted 
was the need for: nomenclature, standards, methodologies, benchmarks and protocols; 
development of best practice guidelines; voluntary schemes on responsibility; and databases 
of MNMs, research topics and themes.  
 
Broadly speaking, NIN’s stakeholder sessions have shown: that regulatory agencies are 
confident in Europe’s monitoring, control, expertise and legislation, whether for chemicals, 
pharmaceuticals or food; that industries using or producing MNMs are positive that they have 
the know-how to deal with MNMs because they see them as chemical, pharmaceutical or 
biological problems - they do not wish to take undue risks with MNMs; and that consumers 
will probably embrace nanotechnologies which improve their lives, as long as communication 
on risks is transparent and from trustworthy sources. 
 
Our workshops have shown that NIN researchers and other stakeholders share very similar 
knowledge needs, and that open communication and free movement of knowledge are 
wanted by and will benefit all parties. We encourage all organisations with a stake in the 
possible health and environmental impacts that nanotechnologies may have to be active 
members of NIN, to ensure safe and responsible development, production, use and disposal 
of MNMs. 
 
Funding: NanoImpactNet is a Coordination Action funded by the European Commission's 7th 
Framework Programme (GA218539).  
